Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
18.41
+0.25 (1.38%)
At close: May 22, 2026, 4:00 PM EDT
18.05
-0.36 (-1.96%)
After-hours: May 22, 2026, 7:22 PM EDT
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Amphastar Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of $23.33. The average 1-year stock price forecast is 26.72% higher than the current stock price, while the lowest is $19 (+3.20%) and the highest is $30 (+62.95%).
Price Target: $23.33 (+26.72%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 2 | 2 | 2 | 0 |
| Hold | 4 | 4 | 4 | 4 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 7 | 7 | 8 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $30 → $19 | Buy → Hold | Downgrades | $30 → $19 | +3.20% | May 14, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $25 → $21 | Hold | Reiterates | $25 → $21 | +14.07% | May 11, 2026 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 8, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $30 → $22 | Strong Buy → Hold | Downgrades | $30 → $22 | +19.50% | Apr 21, 2026 |
| Barclays | Barclays | Hold Maintains $30 → $23 | Hold | Maintains | $30 → $23 | +24.93% | Apr 8, 2026 |
Financial Forecast
Revenue This Year
761.69M
from 719.89M
Increased by 5.81%
Revenue Next Year
804.22M
from 761.69M
Increased by 5.58%
EPS This Year
2.81
from 2.03
Increased by 38.30%
EPS Next Year
3.34
from 2.81
Increased by 19.03%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 797.3M | 857.9M | ||||||
| Avg | 761.7M | 804.2M | ||||||
| Low | 716.0M | 737.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 10.8% | 12.6% | ||||||
| Avg | 5.8% | 5.6% | ||||||
| Low | -0.5% | -3.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.16 | 3.71 | ||||||
| Avg | 2.81 | 3.34 | ||||||
| Low | 2.41 | 2.83 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 55.7% | 32.3% | ||||||
| Avg | 38.3% | 19.0% | ||||||
| Low | 18.8% | 0.9% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.